Read about our latest initiatives, program updates, and important announcements in the fight against HIV/AIDS in Zimbabwe.
Tendai Gukutikwa Health Reporter GOVERNMENT is set to significantly expand access to the new HIV prevention drug, Lenacapavir in Manicaland, with Mutare, Chipinge and Buhera among the districts earmarked for rollout in the second phase of the programme beginning next month. The development will increase access to one of the world's most promising HIV prevention interventions, which provides long-lasting protection through just two injections a year.
Read More
The National AIDS Council (NAC) has brought together traditional healers, herbalists and faith healers from across the country for a three-day workshop to strengthen Zimbabwe's response to HIV, tuberculosis and non-communicable diseases.
Read More
TRADITIONAL medical practitioners and herbalists have appealed to the National AIDS Council (NAC) to be supplied with HIV rapid testing kits to enhance early diagnosis and improve the referral system of patients to mainstream health facilities.
Read More
AFRICAN Health Ministers have committed to adopting a unified continental position aimed at accelerating efforts to end HIV and AIDS as a public health threat by 2030, amid growing concerns over global funding uncertainties and the future sustainability of HIV programmes.
Read More
The United States has launched lenacapavir (LEN), the new long-acting HIV prevention drug, in Zimbabwe, with plans to support thousands op poeple.
Read More
Zimbabwe has taken a decisive step forward in strengthening its national health system with the official commissioning of Nucleic Acid Testing (NAT) for blood screening at the National Blood Service Zimbabwe (NBSZ) headquarters in Harare.
Read More